blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3426351

EP3426351 - BENZOPIPERIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND HEMOGLOBINOPATHIES [Right-click to bookmark this link]
Former [2019/03]BENZOPIPERIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND HEMOGLOBINOPATHIES
[2019/36]
StatusNo opposition filed within time limit
Status updated on  18.10.2021
Database last updated on 19.10.2024
FormerThe patent has been granted
Status updated on  06.11.2020
FormerGrant of patent is intended
Status updated on  21.07.2020
FormerRequest for examination was made
Status updated on  15.06.2020
FormerGrant of patent is intended
Status updated on  05.02.2020
FormerRequest for examination was made
Status updated on  10.01.2020
FormerGrant of patent is intended
Status updated on  27.08.2019
FormerRequest for examination was made
Status updated on  14.12.2018
FormerThe international publication has been made
Status updated on  15.09.2017
Formerunknown
Status updated on  20.03.2017
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT
published on 16.10.2024  [2024/42]
Applicant(s)For all designated states
CTxT Pty Ltd
343 Royal Parade
Parkville, VIC 3052 / AU
[2019/52]
Former [2019/39]For all designated states
CTXT Pty Limited
343 Royal Parade
Parkville, VIC 3052 / AU
Former [2019/03]For all designated states
Ctxt Pty Ltd
343 Royal Parade
Parkville, Victoria 3052 / AU
Inventor(s)01 / BERGMAN, Ylva Elisabet
Monash Institute of Pharmaceutical Sciences
381 Royal Parade
Parkville Victoria 3052 / AU
02 / CAMERINO, Michelle Ang
Monash Institute of Pharmaceutical Sciences
381 Royal Parade
Parkville Victoria 3052 / AU
03 / STUPPLE, Paul Anthony
Monash Institute of Pharmaceutical Sciences
381 Royal Parade
Parkville Victoria 3052 / AU
 [2019/03]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2020/50]
Former [2019/03]Watson, Robert James, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Application number, filing date17709956.109.03.2017
[2019/03]
WO2017EP55537
Priority number, dateGB2016000403009.03.2016         Original published format: GB 201604030
[2019/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017153520
Date:14.09.2017
Language:EN
[2017/37]
Type: A1 Application with search report 
No.:EP3426351
Date:16.01.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 14.09.2017 takes the place of the publication of the European patent application.
[2019/03]
Type: B1 Patent specification 
No.:EP3426351
Date:09.12.2020
Language:EN
[2020/50]
Search report(s)International search report - published on:EP14.09.2017
ClassificationIPC:A61P35/00, A61P7/06, C07D401/12, A61K31/444, A61K31/451, A61K31/4725, A61K31/496, A61K31/5377, A61K31/553
[2019/03]
CPC:
C07D401/12 (EP); C07D401/14 (US); A61P35/00 (EP);
A61P7/06 (EP); C07D413/14 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/03]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:BENZOPIPERIDINDERIVATE UND DEREN VERWENDUNG IN DER BEHANDLUNG VON KREBS UND HÄMOGLOBINPATHIEN[2019/03]
English:BENZOPIPERIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND HEMOGLOBINOPATHIES[2020/50]
French:DÉRIVÉS DE BENZOPIPÉRIDINE ET LEUR UTILISATION DANS LE TRAITEMENT DU CANCER ET DES HÉMOGLOBINOPATHIES[2019/03]
Former [2019/03]BENZOPIPERIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND HEMOGLOBINOPATHIES
Entry into regional phase04.09.2018National basic fee paid 
04.09.2018Designation fee(s) paid 
04.09.2018Examination fee paid 
Examination procedure04.09.2018Examination requested  [2019/03]
04.09.2018Date on which the examining division has become responsible
25.04.2019Amendment by applicant (claims and/or description)
28.08.2019Communication of intention to grant the patent
02.01.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
06.02.2020Communication of intention to grant the patent
12.06.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
22.07.2020Communication of intention to grant the patent
03.11.2020Fee for grant paid
03.11.2020Fee for publishing/printing paid
03.11.2020Receipt of the translation of the claim(s)
Opposition(s)10.09.2021No opposition filed within time limit [2021/46]
Fees paidRenewal fee
18.03.2019Renewal fee patent year 03
10.03.2020Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.03.2017
AL09.12.2020
AT09.12.2020
CY09.12.2020
CZ09.12.2020
DK09.12.2020
EE09.12.2020
ES09.12.2020
FI09.12.2020
HR09.12.2020
IT09.12.2020
LT09.12.2020
LV09.12.2020
MC09.12.2020
MK09.12.2020
MT09.12.2020
NL09.12.2020
PL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SI09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
IE09.03.2021
LU09.03.2021
NO09.03.2021
GR10.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
IS09.04.2021
PT09.04.2021
[2024/42]
Former [2024/22]HU09.03.2017
AL09.12.2020
AT09.12.2020
CY09.12.2020
CZ09.12.2020
DK09.12.2020
EE09.12.2020
ES09.12.2020
FI09.12.2020
HR09.12.2020
IT09.12.2020
LT09.12.2020
LV09.12.2020
MC09.12.2020
MK09.12.2020
NL09.12.2020
PL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SI09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
IE09.03.2021
LU09.03.2021
NO09.03.2021
GR10.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
IS09.04.2021
PT09.04.2021
Former [2023/33]HU09.03.2017
AL09.12.2020
AT09.12.2020
CY09.12.2020
CZ09.12.2020
DK09.12.2020
EE09.12.2020
ES09.12.2020
FI09.12.2020
HR09.12.2020
IT09.12.2020
LT09.12.2020
LV09.12.2020
MC09.12.2020
NL09.12.2020
PL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SI09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
IE09.03.2021
LU09.03.2021
NO09.03.2021
GR10.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
IS09.04.2021
PT09.04.2021
Former [2023/30]AL09.12.2020
AT09.12.2020
CY09.12.2020
CZ09.12.2020
DK09.12.2020
EE09.12.2020
ES09.12.2020
FI09.12.2020
HR09.12.2020
IT09.12.2020
LT09.12.2020
LV09.12.2020
MC09.12.2020
NL09.12.2020
PL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SI09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
IE09.03.2021
LU09.03.2021
NO09.03.2021
GR10.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
IS09.04.2021
PT09.04.2021
Former [2022/34]AL09.12.2020
AT09.12.2020
CZ09.12.2020
DK09.12.2020
EE09.12.2020
ES09.12.2020
FI09.12.2020
HR09.12.2020
IT09.12.2020
LT09.12.2020
LV09.12.2020
MC09.12.2020
NL09.12.2020
PL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SI09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
IE09.03.2021
LU09.03.2021
NO09.03.2021
GR10.03.2021
BE31.03.2021
CH31.03.2021
LI31.03.2021
IS09.04.2021
PT09.04.2021
Former [2022/23]AL09.12.2020
AT09.12.2020
CZ09.12.2020
DK09.12.2020
EE09.12.2020
ES09.12.2020
FI09.12.2020
HR09.12.2020
IT09.12.2020
LT09.12.2020
LV09.12.2020
MC09.12.2020
NL09.12.2020
PL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SI09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
IE09.03.2021
LU09.03.2021
NO09.03.2021
GR10.03.2021
CH31.03.2021
LI31.03.2021
IS09.04.2021
PT09.04.2021
Former [2022/10]AL09.12.2020
AT09.12.2020
CZ09.12.2020
DK09.12.2020
EE09.12.2020
ES09.12.2020
FI09.12.2020
HR09.12.2020
IT09.12.2020
LT09.12.2020
LV09.12.2020
MC09.12.2020
NL09.12.2020
PL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SI09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
IE09.03.2021
LU09.03.2021
NO09.03.2021
GR10.03.2021
CH31.03.2021
LI31.03.2021
PT09.04.2021
Former [2022/08]AL09.12.2020
AT09.12.2020
CZ09.12.2020
DK09.12.2020
EE09.12.2020
ES09.12.2020
FI09.12.2020
HR09.12.2020
IT09.12.2020
LT09.12.2020
LV09.12.2020
MC09.12.2020
NL09.12.2020
PL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SI09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
IE09.03.2021
LU09.03.2021
NO09.03.2021
GR10.03.2021
IS09.04.2021
PT09.04.2021
Former [2022/07]AL09.12.2020
AT09.12.2020
CZ09.12.2020
DK09.12.2020
EE09.12.2020
FI09.12.2020
HR09.12.2020
IT09.12.2020
LT09.12.2020
LV09.12.2020
MC09.12.2020
NL09.12.2020
PL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SI09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
IE09.03.2021
NO09.03.2021
GR10.03.2021
IS09.04.2021
PT09.04.2021
Former [2021/49]AL09.12.2020
AT09.12.2020
CZ09.12.2020
DK09.12.2020
EE09.12.2020
FI09.12.2020
HR09.12.2020
IT09.12.2020
LT09.12.2020
LV09.12.2020
MC09.12.2020
NL09.12.2020
PL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SI09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
NO09.03.2021
GR10.03.2021
IS09.04.2021
PT09.04.2021
Former [2021/48]AL09.12.2020
AT09.12.2020
CZ09.12.2020
EE09.12.2020
FI09.12.2020
HR09.12.2020
IT09.12.2020
LT09.12.2020
LV09.12.2020
MC09.12.2020
NL09.12.2020
PL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
NO09.03.2021
GR10.03.2021
IS09.04.2021
PT09.04.2021
Former [2021/45]AL09.12.2020
AT09.12.2020
CZ09.12.2020
EE09.12.2020
FI09.12.2020
HR09.12.2020
LT09.12.2020
LV09.12.2020
MC09.12.2020
NL09.12.2020
PL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
NO09.03.2021
GR10.03.2021
IS09.04.2021
PT09.04.2021
Former [2021/42]AT09.12.2020
CZ09.12.2020
EE09.12.2020
FI09.12.2020
HR09.12.2020
LT09.12.2020
LV09.12.2020
NL09.12.2020
PL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
NO09.03.2021
GR10.03.2021
IS09.04.2021
PT09.04.2021
Former [2021/39]AT09.12.2020
CZ09.12.2020
EE09.12.2020
FI09.12.2020
HR09.12.2020
LT09.12.2020
LV09.12.2020
NL09.12.2020
PL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
NO09.03.2021
GR10.03.2021
PT09.04.2021
Former [2021/37]AT09.12.2020
CZ09.12.2020
EE09.12.2020
FI09.12.2020
HR09.12.2020
LT09.12.2020
LV09.12.2020
NL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
NO09.03.2021
GR10.03.2021
PT09.04.2021
Former [2021/36]CZ09.12.2020
EE09.12.2020
FI09.12.2020
HR09.12.2020
LT09.12.2020
LV09.12.2020
NL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
NO09.03.2021
GR10.03.2021
PT09.04.2021
Former [2021/35]CZ09.12.2020
FI09.12.2020
HR09.12.2020
LT09.12.2020
LV09.12.2020
NL09.12.2020
RO09.12.2020
RS09.12.2020
SE09.12.2020
SK09.12.2020
SM09.12.2020
BG09.03.2021
NO09.03.2021
GR10.03.2021
PT09.04.2021
Former [2021/33]FI09.12.2020
HR09.12.2020
LT09.12.2020
LV09.12.2020
NL09.12.2020
RS09.12.2020
SE09.12.2020
SM09.12.2020
BG09.03.2021
NO09.03.2021
GR10.03.2021
PT09.04.2021
Former [2021/32]FI09.12.2020
HR09.12.2020
LV09.12.2020
NL09.12.2020
RS09.12.2020
SE09.12.2020
SM09.12.2020
BG09.03.2021
NO09.03.2021
GR10.03.2021
Former [2021/30]FI09.12.2020
HR09.12.2020
LV09.12.2020
NL09.12.2020
RS09.12.2020
SE09.12.2020
BG09.03.2021
NO09.03.2021
GR10.03.2021
Former [2021/28]FI09.12.2020
HR09.12.2020
LV09.12.2020
RS09.12.2020
SE09.12.2020
BG09.03.2021
NO09.03.2021
GR10.03.2021
Former [2021/23]FI09.12.2020
LV09.12.2020
RS09.12.2020
SE09.12.2020
BG09.03.2021
NO09.03.2021
GR10.03.2021
Former [2021/22]FI09.12.2020
RS09.12.2020
NO09.03.2021
Former [2021/20]FI09.12.2020
Cited inInternational search[A]WO2014100719  (EPIZYME INC [US]) [A] 1-59* The whole document, but, in particular, claims 1, 118 and 124 *;
 [AP]WO2016034675  (CTXT PTY LTD [AU]) [AP] 1-59 * the whole document *;
 [XP]WO2016034673  (CTXT PTY LTD [AU]) [XP] 1-59 * the whole document *;
 [AP]WO2016034671  (CTXT PTY LTD [AU]) [AP] 1-59 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.